58420-21-6

Basic information

• Product Name: 3-(4-ISOPROPYLPHENYL)PROPIONIC ACID
• Synonyms: 3-(4-ISOPROPYLPHENYL)PROPIONIC ACID;4-Isopropylbenzenepropanoic acid
• CAS NO: 58420-21-6
• Molecular Formula: C₁₂H₁₆O₂
• Molecular Weight: 192.25
• Mol File: 58420-21-6.mol

Chemical Properties

• Melting Point: 74-76°C
• Boiling Point: 310.5°Cat760mmHg
• Flash Point: 207.6°C
• Appearance: /
• Density: 1.047g/cm³
• Vapor Pressure: 0.000257mmHg at 25°C
• Refractive Index: 1.524
• PKA: 4.69±0.10(Predicted)
• CAS DataBase Reference: 3-(4-ISOPROPYLPHENYL)PROPIONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-ISOPROPYLPHENYL)PROPIONIC ACID(58420-21-6)
• EPA Substance Registry System: 3-(4-ISOPROPYLPHENYL)PROPIONIC ACID(58420-21-6)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 36/37/38-22
• Safety Statements: 26-36/37/39
• HazardClass: IRRITANT
• Hazardous Substances Data: 58420-21-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-(4-ISOPROPYLPHENYL)PROPIONIC ACID is used as an antiviral agent for its ability to interfere with viral replication processes, providing a potential treatment option for various viral infections.
Used in Chemical Synthesis:
3-(4-ISOPROPYLPHENYL)PROPIONIC ACID is used as a key intermediate in the synthesis of cytotoxic natural ester sintenin and its twenty-eight analogs, which include nitrogen-containing heterocyclic indole groups. These synthesized compounds have potential applications in cancer research and treatment due to their cytotoxic properties.

InChI:InChI=1/C12H16O2/c1-9(2)11-6-3-10(4-7-11)5-8-12(13)14/h3-4,6-7,9H,5,8H2,1-2H3,(H,13,14)

Upstream product

• 32580-69-1 4-isopropyl-cinnamic acid ethyl ester 
• 64-17-5 ethanol 
• 97438-47-6 Acetic acid (E)-3-(4-isopropyl-phenyl)-propenyl ester 
• 2033-24-1 cycl-isopropylidene malonate 
• 64-18-6 formic acid 
• 122-03-2 (4-isopropylbenzaldehyde) 
• 98-82-8 Isopropylbenzene 
• 2051-18-5 4-isopropylbenzyl chloride 
• 59577-61-6 (4-isopropyl-benzylidene)-malonic acid 
• 3368-21-6 (E)-4-isopropylcinnamic acid 
• 7775-00-0 3-(4'-isopropylphenyl)propanal 
• 4441-89-8 (4-isopropyl-benzyl)-malonic acid 
• 4638-83-9 -essigsaeure 
• 3368-21-6 4-isopropylcinnamic acid 

Downstream Products

• 63457-76-1 1,5-di-(4-isopropyl-phenyl)-3-pentanone 
• 79942-40-8 3-(4-isopropylphenyl)-2-methylpropanol 
• 940618-37-1 C₁₈H₂₀N₂O₃ 
• 1226107-55-6 C₁₈H₂₁NO₂ 
• 918519-17-2 C₁₄H₂₁NO₂ 
• 697306-31-3 3-(4-carboxy-2-nitro-phenyl)-propionic acid 
• 88371-24-8 1,2,3,4-tetrahydro-2-oxo-7-quinolinecarboxylic acid 
• 1027397-80-3 2-Benzylamino-7-isopropyl-1,2,3,4-tetrahydro-naphthalene-2-carbonitrile 
• 1027586-98-6 (2-Aminomethyl-7-isopropyl-1,2,3,4-tetrahydro-naphthalen-2-yl)-benzyl-amine 
• 1026058-84-3 Benzyl-(7-isopropyl-3,4-dihydro-naphthalen-2-yl)-amine 
• 172366-33-5 6-isopropyl-1-methyleneindan 
• 1027090-68-1 5-{5-[3-(4-Isopropyl-phenyl)-propyl]-thiophen-2-yl}-3,3-dimethyl-1-[4-(2,3,4-trimethoxy-benzyl)-piperazin-1-yl]-pentan-1-one 
• 1026263-58-0 5-{5-[3-(4-Isopropyl-phenyl)-propyl]-thiophen-2-yl}-3,3-dimethyl-5-oxo-pentanoic acid 
• 214618-09-4 5-{5-[3-(4-Isopropyl-phenyl)-propyl]-thiophen-2-yl}-3,3-dimethyl-pentanoic acid 

Relevant articles and documents

METHODS OF SYNTHESIZING FARNESYL DIBENZODIAZEPINONES

The present invention is directed to synthetic means for producing farnesyl dibenzodiazepinone compounds, including AMO-01.

HUMAN ETS-RELATED GENE (ERG) COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE

This invention provides compound having a structure of Formula (I): (I) Uses of such compounds for treatment of ERG, FLI1, ETV4, or ETV1 -mediated indications, including cancer. Also provided are pharmaceutical composition and methods of treating ERG, FLI1, ETV4, or ETV1-mediated indications, including cancer. The cancer may be selected from the group consisting of: prostate cancer, Ewing's sarcoma, breast cancer or pancreatic cancer.

Ansa-Ruthenium(II) Complexes of R2NSO2DPEN-(CH2)n(η6-Aryl) Conjugate Ligands for Asymmetric Transfer Hydrogenation of Aryl Ketones

New 3rd generation designer ansa-ruthenium(II) complexes featuring N,C-alkylene-tethered N,N-dialkylsulfamoyl-DPEN/η6-arene ligands, exhibited good catalytic performance in the asymmetric transfer hydrogenation (ATH) of various classes of (het)aryl ketones in formic acid/triethylamine mixture. In particular, benzo-fused cyclic ketones furnished 98 to >99.9% ee using a low catalyst loading.

Improved synthesis of natural ester sintenin and its analogues via Wittig reaction

The synthesis of a cytotoxic natural ester sintenin (7a) and twenty eight of its analogues including nitrogen-containing heterocyclic indole moiety (7b-7t), saturated (10a-10d) and unsaturated (10e-10h) amides were carried out by convenient route via one-pot Wittig reaction in aqueous medium with improved yield. A systematic structure activity relationship of sintenin ester was designed by chemically modified derivatives in order to get better cytotoxicity.

QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS

Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of formula (Ia) or (Ib) a pharmaceutically acceptable acid or base addition salt thereof, a stereochemically isomeric form thereof, a tautomeric form thereof or a N-oxide form thereof. Several of these compounds are also claimed as such. Further the combination of the above compounds with other antibacterial agents is described

The discovery and synthesis of novel adenosine receptor (A2A) antagonists

In high throughput screening of our file compounds, a novel structure 1 was identified as a potent A2A receptor antagonist with no selectivity over the A1 adenosine receptor. The structure-activity relationship investigation using 1 as a template lead to identification of a novel class of compounds as potent and selective antagonists of A2A adenosine receptor. Compound 26 was identified to be the most potent A2A receptor antagonist (Ki = 0.8 nM) with 100-fold selectivity over the A1 adenosine receptor.